Grünenthal selects Patheon to develop drugs using INTAC abuse deterrent formulations technology
Patheon has signed a strategic agreement with Grünenthal, an independent, family-owned, international research-based pharmaceutical group headquartered in Aachen, Germany to serve as…
Read More...
Read More...
